{
    "nctId": "NCT03109522",
    "briefTitle": "Axillary Reverse Mapping (ARM) Technique",
    "officialTitle": "A Pilot Randomized Controlled Trial Comparing the Axillary Reverse Mapping (ARM) Technique to Standard Axillary Surgery in Breast Cancer Patients.",
    "overallStatus": "UNKNOWN",
    "conditions": "Invasive Breast Cancer, Ductal Carcinoma in Situ of the Breast",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 130,
    "primaryOutcomeMeasure": "Lymphedema",
    "eligibilityCriteria": "Inclusion Criteria: women diagnosed with invasive breast cancer or ductal carcinoma in situ receiving the following treatment:\n\n1. mastectomy and sentinel lymph node biopsy\n2. breast conserving surgery or mastectomy and axillary lymph node dissection\n3. completion axillary lymph node dissection after positive sentinel lymph node biopsy\n4. cases receiving neo-adjuvant therapy (chemotherapy or hormonal therapy) who are having axillary lymph node dissection as part of their surgical treatment -\n\nExclusion Criteria:\n\n1. males with breast cancer\n2. women less than 18 years of age\n3. known allergic reaction to patent blue dye\n4. pregnant\n5. previous radiation therapy to affected side\n6. clinical N2/N3 disease -",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}